Gut microbiota is new frontier in CNS research
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Research Directory
Taking on the Alzheimer's conundrum
Interviewee/ContributorReisa SperlingOrganisationHarvard Medical SchoolRevisiting antibody-drug conjugates
Interviewee/ContributorChris MartinOrganisationADC Therapeutics SAWhy private equity is investing in biopharma
Interviewee/ContributorEmma DabbsOrganisationNovasecta LtdFinding a treatment for mesothelioma
Interviewee/ContributorRob MeijerOrganisationAmphera BVDual inhibition of intracellular enzymes
Interviewee/ContributorTara Rheault Margot MacDonald-BerkoOrganisationVerona Pharma PlcInvestors show caution about biotechs
Interviewee/ContributorWilliam EllingtonOrganisationMedNousThree European biotechs raise nearly $6 billion
Interviewee/ContributorVictoria EnglishOrganisationMedNousThe precedents set by Zolgensma
Interviewee/ContributorVictoria EnglishOrganisationMedNousASCO 2019: Successes and setbacks mark the cancer meeting
Interviewee/ContributorBruno PagliaraOrganisationOn-kòs Pharma Consulting